bi 3000202
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 25, 2023 (NCT05945888)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07273474 | Phase 1 | Dec 15, 2025 | Boehringer Ingelheim |
| NCT07215260 | Phase 1 | Nov 5, 2025 | Boehringer Ingelheim |
| NCT06878365 | Phase 1 | Mar 28, 2025 | Boehringer Ingelheim |
| NCT06419660 | Phase 1 | May 21, 2024 | Boehringer Ingelheim |
| NCT06327256 | Phase 1 | Mar 28, 2024 | Boehringer Ingelheim |
| NCT05945888 | Phase 1 | Jul 25, 2023 | Boehringer Ingelheim |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 6 | 6 | 1 | 2023 |
1 organizations
Page 1 / 1